Arcutis Biotherapeutics Inc Atopic Dermatitis Topline Data Call Transcript
Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics top line data call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Eric McIntyre, Head of Investor Relations. Please go ahead.
Thank you, Michelle. Good morning, everyone, and thanks for joining. We are incredibly excited to be here with you again today to discuss pivotal Phase III results from our INTEGUMENT-1 and 2 trials in atopic dermatitis and certainly also proud of the continued execution on the clinical front and progress towards realizing the long-term value for topical roflumilast. A couple of logistical details before we get started. Our Arcutis management team is all here today, and will also be joined by Dr. Larry Eichenfield during our prepared remarks as well as for Q&A.
You could find today's webcast and posted presentation under the Events and Presentations section of our Investor website.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |